Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice

Saqi, A., Leslie, K. O., Moreira, A. L., Lantuejoul, S., Shu, C. A., Rizvi, N. A., Sonett, J. R., Tajima, K., Sun, S. W., Gitlitz, B. J., & Colby, T. V. (2022). Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice. JTO Clinical and Research Reports, 3(5), 100310. https://doi.org/10.1016/j.jtocrr.2022.100310
Authors:
Anjali Saqi
Kevin O Leslie
Andre L Moreira
Sylvie Lantuejoul
Catherine Ann Shu
Naiyer A Rizvi
Joshua R Sonett
Kosei Tajima
Shawn W Sun
Barbara J Gitlitz
Thomas V Colby
Affiliated Authors:
Anjali Saqi
Catherine Ann Shu
Naiyer A Rizvi
Joshua R Sonett
Columbia Affiliation:
Author Keywords:
early-stage lung cancer
mpr assessment
nsclc
neoadjuvant therapy
pcr
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtocrr.2022.100310
PMID:
35498382
DOI:
10.1016/j.jtocrr.2022.100310
Journal:
JTO Clinical and Research Reports
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: